Filing Details
- Accession Number:
- 0001567619-20-011915
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-09 18:01:33
- Reporting Period:
- 2020-06-05
- Accepted Time:
- 2020-06-09 18:01:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 70487 | National Research Corp | NRC | Services-Commercial Physical & Biological Research (8731) | 470634000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1522907 | R Kevin Karas | C/O National Research Corporation 1245 Q Street Lincoln NE 68508 | Svp Finance, Cfo, Treas & Secy | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-06-05 | 6,858 | $57.28 | 10,718 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-06-05 | 6,718 | $58.62 | 4,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-06-05 | 20,088 | $14.50 | 24,088 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-06-05 | 9,704 | $57.22 | 14,384 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2020-06-05 | 20,088 | $0.00 | 20,088 | $14.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-01-07 | No | 4 | M | Direct |
Footnotes
- The price in Column 4 is a weighted average price. The prices actually received ranged from $57.00 to $57.80, inclusive. The reporting person has provided the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- The price in Column 4 is a weighted average price. The prices actually received ranged from $58.00 to $58.93, inclusive.
- This option became fully exercisable on January 7, 2018.
Billionaire Hedge Funds
